Sort by: Date added | Date Published | Most Viewed

Headlines Tagged with Vaccines 1,075 headlines found

7 Views

CHAMPIX® (Varenicline) European Union Label Updated To Include New Safety And Efficacy Data From The EAGLES Clinical Trial Following Endorsement From CHMP

Pfizer Inc. (NYSE:PFE) today announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX® (varenicline) have been updated to include safety and efficacy data from the EAGLES (Evaluating Adverse Events in a Global
Pfizer
added May 24, 2016 15:46
3 Views

Europe lifts warning on Pfizer smoking cessation drug

European regulators have lifted a warning on Pfizer's smoking cessation drug Champix - called Chantix in the United States - after a clinical study concluded it did not appear to increase the risk of neuropsychiatric side effects.
Reuters
added May 23, 2016 18:45
18 Views

The FDA Needs To Change The Label For The Smoking Cessation Drug, Chantix

Forbes
added May 6, 2016 19:50
6 Views

Health: Study offers hope for stop-smoking drugs

Now Chantix maker Pfizer and Zyban maker GlaxoSmithKline hope the Food and Drug Administration, which ordered them to do the study, will remove the so-called “black box warnings” put on their prescription drugs due to anecdotal patient reports of serious
AP - Associated Press
added May 2, 2016 19:34
5 Views

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

The study did not show a significant increase in neuropsychiatric adverse events attributable to varenicline or bupropion relative to nicotine patch or placebo. Varenicline was more effective than placebo, nicotine patch, and bupropion in helping smokers
The Lancet (uk)
added Apr 25, 2016 14:46
8 Views

Chantix, Wellbutrin Found Safe in Smokers with Psych Disorders

Smokers with psychiatric disorders who took the stop-smoking drug varenicline (Chantix) or the antidepressant bupropion (Wellbutrin) in an effort to kick the habit were no more likely to experience serious neuropsychiatric side effects than those who use
MedPage Today
added Apr 25, 2016 14:45
3 Views

Debunked: Claims That Chantix And Zyban Smoking Cessation Drugs Boost Risk Of Psychiatric Side Effects

The smoking cessation aids varenicline (Chantix) and bupropion (Zyban) do not show a significant increase in neuropsychiatric adverse events compared to the nicotine patch and a placebo, according to data published in The Lancet. After reports claiming v
Science 2.0
added Apr 24, 2016 23:42
4 Views

Study: No suicide risk for anti-smoking pills Chantix, Zyban

Seven years after U.S. regulators slapped their strictest warning on two popular smoking-cessation medicines citing risks of suicidal behavior, a large international study found no such risk. Now Chantix maker Pfizer and Zyban maker GlaxoSmithKline hope
AP - Associated Press
added Apr 23, 2016 22:57
5 Views

CHANTIX®/CHAMPIX® (varenicline) Results from the Largest Global Clinical Trial of Smoking Cessation Medicines Published in The Lancet

Authors conclude no significant increase in serious neuropsychiatric adverse events with CHANTIX/CHAMPIX relative to placebo or nicotine patch Smokers treated with CHANTIX/CHAMPIX had significantly higher quit rates than those treated with bupropion, ni
Business Wire
added Apr 23, 2016 22:55
5 Views

No Link Between Anti-Smoking Drugs, Mental Health Issues: Study

The anti-smoking drugs Chantix (varenicline) and Wellbutrin (bupropion) don't appear to raise the risk of serious mental health disorders such as depression, anxiety and suicidal thoughts, a new study suggests. "Clinical guidelines recommend that the mos
HealthDay [HealthScout]
added Apr 23, 2016 22:38
Sign up for daily headlines All Headlines Featured Headlines U.S. Headlines International Headlines